Phase Ib/Ii Open-Label, Randomized Evaluation Of Second- Or Third-Line (2l/3l) Atezolizumab (Atezo) Plus Entinostat (Entino) In Morpheus-Hr Plus Breast Cancer (M-Hr Plus Bc) A. Sonnenblick,S-A. Im,K. S. Lee,A. Tan, M. Telli,S. Strulov Shachar,F. Bene Tchaleu,E. Cha, K. Dupree, M. Nikanjam, C. Shemesh, J. Xu,X. Zhang, J. Zhu,H. S. RugoANNALS OF ONCOLOGY（2021）引用 2|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
